Orion

Merck opts in on Orion's hormone-dependent cancer candidates
Fierce Biotech
Mon, 07/1/24 - 09:51 pm
Merck
Orion
biobucks
cancer
MHRA, NHS England make available new prostate cancer treatment
Pharmaphorum
Mon, 11/28/22 - 07:32 pm
Bayer
Orion
prostate cancer
England
Months after slimming its R&D focus, Orion realigns stars in top-down organizational restructure
Fierce Biotech
Mon, 10/17/22 - 10:49 am
Orion
restructuring
layoffs
R&D
Finland
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
Orion raises outlook after Merck deal on developing prostate cancer drug
Reuters
Wed, 07/13/22 - 10:40 am
Orion
Merck
prostate cancer
drug development
A Bayer partner slims down, trimming R&D and enacting layoffs, to better focus on the pair's prostate cancer work
Endpoints
Thu, 03/24/22 - 10:53 am
Orion
Bayer
prostate cancer
layoffs
R&D
Bayer’s Nubeqa scores key prostate cancer win in battle with Pfizer, J&J
Fierce Pharma
Thu, 01/30/20 - 09:15 pm
Bayer
Orion
Nubeqa
prostate cancer
clinical trials
Bayer, Orion win speedy approval for prostate cancer drug darolutamide
Endpoints
Wed, 07/31/19 - 08:51 am
Bayer
Orion
prostate cancer
darolutamide
FDA
FDA tags Bayer's prostate cancer drug for priority review as drugmaker gears up against rivals
Endpoints
Mon, 04/29/19 - 12:02 pm
Bayer
Orion
prostate cancer
priority review
daralutamide
FDA
Propeller, Orion to develop digital asthma, COPD therapy
Drug Delivery Business News
Mon, 02/11/19 - 08:07 pm
Propeller Health
devices
Orion
asthma
COPD
Easyhaler
Orion takes repurposed heart failure drug into phase 3 for ALS
Fierce Biotech
Fri, 07/6/18 - 10:13 am
Orion
ALS
ODM-109
clinical trials
Orion inks $200m deal to sell diagnostics unit
Drug Delivery Business News
Mon, 04/23/18 - 10:41 pm
Orion
Axcel Management
M&A
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Europe
drug approvals
Kadcyla
Roche
Bayer
Xofigo
Abilify Maintena
Otsuka
Lundbeck
Memantine Accord
Accord Healthcare
Levodopa Carbidopa Entacapone Sandoz
Orion
Vitekta
Gilead
Janssen-Cilag
Invokana
Novo Nordisk
NovoEight
AstraZeneca
Fluenz Tetra
GSK
Relvar Ellipta
Lidocaine/Prilocaine Plethora
Plethora Solutions
Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial
Mon, 01/16/12 - 10:08 pm
Boston Scientific
Orion
clinical trials
Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
Yahoo
Fri, 01/28/11 - 09:40 am
Endo
Orion
R&D
cancer
Novartis, Orion’s Stalevo Drug May Have Cancer Risk
Bloomberg
Thu, 04/1/10 - 09:42 am
Novartis
Orion
Stalevo
prostate cancer
Parkinson's Disease